| 1. | | Recruiting | Study of Unrelated Allogeneic Bone Marrow Transplantation in Patients With Benign Congenital Bone Marrow Failure Disorders
Conditions: Graft Versus Host Disease; Neutropenia; Shwachman syndrome; Red-Cell Aplasia, Pure; Osteopetrosis |
| 2. | | Recruiting | International Registry for Severe Chronic Neutropenia
Condition: Neutropenia |
| 3. | | Recruiting | Prophylaxis Trial of Posaconazole vs. Standard Azole Therapy for Neutropenic Patients
Conditions: Leukemia, Myelocytic, Acute; Myelodysplastic Syndromes; Neutropenia |
| 4. | | Recruiting | Gene Message (mRNA) Analysis of Granulocytes
Condition: Neutropenia |
| 5. | | Recruiting | Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Anemia; Drug Toxicity; Neutropenia; Non-small cell lung cancer |
| 6. | | Recruiting | Pegfilgrastim in Treating Neutropenia After Chemotherapy in Patients With Mantle Cell or Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; Mantle Cell Lymphoma; Neutropenia |
| 7. | | Recruiting | Investigating Voriconazole to Prevent Systemic Fungal Infection
Conditions: Neutropenia; Leukemia; Lymphoma; Aplastic Anemia |
| 8. | | Recruiting | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
Conditions: adult solid tumor; fever, sweats, and hot flashes; hematopoietic and lymphoid cancer; Infection; Neutropenia |
| 9. | | Recruiting | Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
Conditions: Sarcoma; Neutropenia |
| 10. | | Recruiting | Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Conditions: Anemia; Chronic Lymphocytic Leukemia; Neutropenia; Thrombocytopenia |
| 11. | | Recruiting | Screening for Hematology Branch Protocols
Conditions: Anemia; Hematologic Neoplasm; Neutropenia; Pancytopenia; Thrombocytopenia |
| 12. | | Recruiting | Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17
Condition: Febrile Neutropenia |
| 13. | | Recruiting | Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients
Conditions: Neutropenia; Fever |
| 14. | | Recruiting | Anidulafungin in Treating Immunocompromised Children With Neutropenia
Conditions: Infection; Neutropenia; unspecified childhood solid tumor, protocol specific |
| 15. | | Recruiting | Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer
Condition: Neutropenia |
| 16. | | Recruiting | Cancer in Inherited Bone Marrow Failure Syndromes
Conditions: Fanconi's Anemia; Anemia, Diamond-Blackfan; Dyskeratosis Congenital; Thrombocytopenia; Neutropenia |
| 17. | | Recruiting | Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
Condition: Aplastic Anemia |
| 18. | | Recruiting | Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected with HCV Genotype 2 or 3
Condition: Hepatitis C |
| 19. | | Recruiting | Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts after Intensive Chemotherapy
Conditions: Ewing's Sarcoma; Rhabdomyosarcoma; Sarcoma; Synovial Sarcoma |
| 20. | | Recruiting | Follow-up Protocol for Patients with Cancer/AIDS/Skin Disease
Conditions: Acquired Immunodeficiency Syndrome; Neoplasm; Skin Disease; HIV Infections |
| 21. | | Recruiting | Evaluation, Treatment, and Training for Patients with Blood Disorders
Conditions: Hematologic Disease; Hematologic Neoplasm; Pancytopenia |
| 22. | | Recruiting | Docetaxel and Gemcitabine with Filgrastim-SD/01 Support in Patients with Advanced Non-Small Cell Lung Carcinoma
Condition: Non-small cell lung cancer |
